Maternal-Fetal Medicine
Treating complicated pregnancies is our priority. We provide care for the entire spectrum of conditions related to high-risk pregnancy, and for women whose pregnancies require special testing, monitoring, treatment, and care. We offer state-of-the-art approaches to caring for women with high-risk pregnancies related to diabetes, hypertension, heart disease, and genetic disorders, among other medical conditions that can complicate a pregnancy.
Maternal-Fetal Medicine (MFM) at Yale pioneered the development of chorionic villus sampling (CVS) and fetal blood sampling (FBS), and has the most experienced team for these procedures in New England. In addition, our skilled specialists, who are internally recognized for their expertise, conduct fetal echocardiography to diagnose congenital heart disorders of the fetus.
Our Services
We offer a variety of services for our patients across the following specialty programs:
- High-Risk Pregnancy Program, which supports ongoing care and management for women with a history of pregnancy risks or current medical complications.
- Prenatal Genetic Diagnostic Program, which provides expert genetic screening and testing for MFM patients. Available tests include first-trimester screening, CVS, amniocentesis, and FBS. After diagnosis, we provide counseling and connect patients when necessary to appropriate support networks to help parents adjust to and prepare for their child's special needs.
- Recurrent Pregnancy Loss Program, offered in conjunction with Yale’s Reproductive Endocrinology and Infertility Section. Our multidisciplinary team of pathologists, geneticists, and perinatologists uses a whole-patient approach to help couples with recurrent miscarriages and/or pregnancy losses.
Other services offered in our MFM section include:
- First-trimester risk assessment for Down Syndrome
- Targeted ultrasound
- Fetal therapy, including percutaneous umbilical blood sampling (PUBS) and intrauterine transfusion
- Antenatal testing
- Diabetes management
MFM physicians can also co-manage patients with high-risk pregnancies with referring practitioners. We can develop care plans with community obstetricians for cases that require intensive oversight by the team, or consultative guidance alone.
Our Programs
Fact Sheets
News
Clinical Trials
A prospective, natural history study to assess the occurrence of HPA-1a alloimmunization in women identified at higherrisk for Fetal and Neonatal Alloimmune Thrombocytopenia(FNAIT)
- Ages18 years and older
- GenderFemale only
- Pregnancy and Obstetrics
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (PROSPECT)
- GenderBoth